We have over 60 years experience in... Peristaltic pumps, tube and hose pumps, sine pumps, liquid filling and OEM pumps
+353 (0) 21 4757030
This site in other countries / regions:
+353 (0) 21 4757030
New sterile ReNu SU Technology cartridge available with aseptic connectors
Rugged, compact industrial process pumps for dosing, metering and transfer duties. Flow rates up to 108,000 litre/hour, (16bar)
Accurate and safe chemical dosing pumps without seals, glands or valves to corrode or wear.
Low shear handling of food and beverages and rapid transfer of high viscosity products without degradation.
Rugged and trouble-free pumps for auto-desludging, digester feed, dewatering, flocculation and chemical dosing.
Pump thicker slurries with ease and use less water. Less downtime and better lifecycle costs.
Working with you to specify and manufacture pumps which will secure your product reliability and reputation.
In light of the current global COVID-19 situation, the Watson-Marlow Fluid Technology Group has implemented rigorous contingency plans to minimise the impact. As the situation continues to develop, please be assured we remain committed to safeguarding the health and well-being of our employees and customers.
WMFTG has launched BioPure silicone transfer tubing to provide a safe, reliable and value-based solution for a wide range of bioprocess fluid transfer applications.
WMFTG can now supply its ReNu SU (single-use) Technology cartridges with aseptic connections and sterility assurance for quick and secure fluid path connection.
Nicholas Anderson, Group Chief Executive, commenting on the results said: “We are pleased to report strong organic sales growth of 8% in the first half of the year and organic operating profit growth of 4%, with all three businesses delivering organic sales growth ahead of industrial production.
Watson-Marlow Fluid Technology Group (WMFTG) announces the expansion of its puresu® single-use range, providing a combination of components that are safe and easy-to-install. Puresu is ideal for the end-to-end manufacture of biopharmaceuticals and personalised medicines, such as gene therapies.
At this point in the spread of the virus, speed is of the essence and vaccine manufacturers need agile, reliable partners who can actively support them in this fight and also in the development of traditional vaccines and other essential medicines.READ MORE...